FOLFIRINOX shows promise as a second-line option for advanced biliary tract cancer
Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies.